The good Dr. should have made sure that his PR company included names and symbols of all current blood substitute researchers/manufacturer's, including the ones that failed, in the PR so that this news release would have popped on all the attendant investors screens.
A good PR company, and I have no reason to believe that this firm is not a very good one, but they should look for as wide a dissemination of this PR as possible. Very possibly they don't understand how the PR's integrate to all the on-line information services and further integrate to the individual screens in peoples offices and homes.
Jeeesh, if we could include even the most obscure reference to Baxter, J&J, Pfizer, Merck, Abbott Labs, even Microsoft, (only kidding, I think,) etc., we would get millions of more eyeball's looking at this PR. Don't forget to also include the ticker symbols of these companies in the PR.
Not really difficult and maybe they can do a re-word and re-release again this AM. Quickly though so as not to lose the moment.
Rich |
